Quigley Jill M.
SEC Form 4 insider trading activity
Quigley Jill M. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 5, 2025.
On the most recent filing, Quigley Jill M. is listed as Director at Terns Pharmaceuticals, Inc. Inside the rolling window, Quigley Jill M. reported no open-market purchases and 1 open-market sale totaling $441K in TERN.
Companies traded
Other insiders at TERN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$441K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Quigley Jill M. made?
Quigley Jill M. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.
Which companies does Quigley Jill M. trade?
Quigley Jill M. has filed SEC Form 4 disclosures for 1 company, including TERN.
When was Quigley Jill M.'s most recent SEC Form 4 filing?
Quigley Jill M.'s most recent SEC Form 4 filing on Tracefour is dated Nov 5, 2025.
What is Quigley Jill M.'s total buy and sell value in the current window?
Inside the rolling retention window, Quigley Jill M. bought $0 and sold $441K based on SEC Form 4 filings.
What was Quigley Jill M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 24,520 TERN shares on 2025-11-04, worth $441K, per SEC Form 4 filings.